What is HIVE?
HIVE is a remote patient monitoring company devoted to improving medication adherence and reducing unplanned readmissions for the 3 million patients on home infusion therapies. These patients self-administer long-term IV medication under the remote supervision of their clinician. The problem is that clinicians don’t have good options for monitoring their patients to make sure they take their medication safely and correctly. For example, of the 3 million patients prescribed at-home IV antibiotics, 20% are readmitted, and each readmission costs $80,000. Clinicians currently call every patient, a process that is time-consuming, subjective, and ineffective. HIVE has developed the only device to solve this problem. Our patent-pending CloudConnect smart catheter leverages a simple mechanoelectrical sensor that wirelessly reports objective medication administration data in real-time, so clinicians can make informed treatment decisions to prevent costly and dangerous readmissions